Manuscripts
April 28, 2022
Cancer registry data linkage of electronic health record data from ASCO's CancerLinQ: Evaluation of advantages, limitations, and lessons learned
JCO Clinical Cancer Informatics
Charlton M et al
February 22, 2022
Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ study
Breast Cancer Research and Treatment
Miller RS et al
January 7, 2022
Quantitating and assessing interoperability between electronic health records
Journal of the American Medical Informatics Association
Bernstam E et al
January 5, 2022
The Chasm between Cancer Quality Measures and EHR Data Quality
JCO Clinical Cancer Informatics
Schorer A et al
October 18, 2021
The Friends of Cancer Research Real World Data (RWD) Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies
Clinical Pharmacology & Therapeutics
Rivera D et al
October 4, 2021
Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach
The Journal for ImmunoTherapy of Cancer
Heilbroner SP et al
September 24, 2021
Survival in the real world: A national analysis of patients treated for early-stage breast cancer
JCO Oncology Practice
Gidwani R et al
June 1, 2021
Summary of the 12 Most Common Cancers in the CancerLinQ Discovery (CLQD) Database
JCO Clinical Cancer Informatics
Potter D et al
March 11, 2021
Identification of transgender people with cancer in electronic health records (EHR): Recommendations based on CancerLinQ observations
JCO Oncology Practice
Alpert AB et al
Abstracts
June 2, 2023
Assessment of electronic health record (EHR)-based machine learning (ML) in predicting risk of brain metastasis among patients with early-stage non-small-cell lung cancer (eNSCLC)
ASCO Annual Meeting 2023
Honarvar H et al
June 2, 2023
Electronic health record (EHR)-based machine learning (ML) to predict disease recurrence after surgical resection of early-stage non-small cell lung cancer (eNSCLC)
ASCO Annual Meeting 2023
Pisano S et al
June 2, 2023
Identification of biomarkers for early progression in muscle invasive bladder cancer (MIBC) using real-world data
ASCO Annual Meeting 2023
Singh N et al
June 2, 2023
Evaluating clinical trial inclusion/exclusion criteria from claims using generative artificial intelligence
ASCO Annual Meeting 2023
Mueller J et al
June 2, 2023
Development of natural language processing (NLP) models for extracting key features from unstructured notes to create real-world data (RWD) assets for clinical research at scale
ASCO Annual Meeting 2023
Agrawal S et al
June 2, 2023
Enhancement in line of therapy (LoT) derivation from real-world data (RWD) from electronic health records (EHR) via integration of medical claims data
ASCO Annual Meeting 2023
Agrawal S et al
June 2, 2023
Site of metastasis (SoM) and its impact on clinical outcomes in 8 cancer cohorts
ASCO Annual Meeting 2023
George R et al
June 2, 2023
Treatment patterns and outcomes among locally advanced cervical cancer patients receiving concurrent chemoradiotherapy
ASCO Annual Meeting 2023
Coutinho F et al
June 2, 2023
Real-world outcomes in patients (pts) with metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan (SG) in 2L+ in the United States (US)
ASCO Annual Meeting 2023
Kalinsky K et al
